Summary.-Griseofulvin, an antibiotic used to treat dermatophytosis, was tested for carcinogenicity in mice, rats and hamsters. Three groups of mice and rats were given the drug in powdered diet in alternating 5-week periods for life, at dose levels of 3.000, 1-500 and 0-300 (mice) and 2.0%, 1-0% and 0-2% (rats). A group of mice and 3 groups of hamsters received continuous daily treatment for life with griseofulvin at 3-000, 1.5%, 0.300 and 0.1% dose levels respectively. A significant incidence of hepatic tumours was observed at the 2 higher treatment levels in mice. Also, statistically significant rates (P < 0.001 and/or P < 0.020) of thyroid tumours, indicating a dose-response, were recorded in male rats at the 2.00/ 1-0%0, and 0 2% dose levels, and in females at the 2.0°, and 1.0% dose levels. Hamsters did not develop neoplasms in response to treatment at any level.
GRISEOFULVIN (Fulvicin grisactin)
, an antibiotic derivative of penicillium moulds, was first isolated from Penicillium griseofulviarnt (Oxford et al., 1939) . Structurally, the compound is 7-chloro-2'4,6-trimethoxy-6'-methylspirobenzofuran-2(3H), 1'-[2]cyclohexene-3,4'-dione (Fig. 1) . It has been used extensively as an antifungal agent to treat superficial dermatomycoses in humans (Anderson, 1965; Beare et al., 1968; Blank et al., 1959) and animals (Beare et al., 1968; Blank et al., 1959) . Griseofulvin has also been successfully used in World Health Organizationsponsored mass treatment campaigns for tinea capitis (Anonymous [WHO], 1966; Grin, 1965) and in field trials for prophylaxis of superficial dermatophytoses (Ballo and Cutting, 1970) . Although the drug is valuable in controlling superficial infection and, in general, causes no notable side effects, there have been reports in humans of transitory leucopenia, granulocytopenia (Blank et al., 1959) , acute intermittent porphyria (Eales, 1963; Redeker et al., 1964) and increased faecal and erythrocytic protoporphyrin at normal therapeutic dose levels (Blank et al., 1959; Rimington et al., 1963) .
In biological experiments, the compound has induced mitotic arrest at the metaphase stage (DeMatteis, 1963; Walpole, 1958, 1960) and potentiated the toxic effects of colchicine (Epstein and Larson, 1961) . Griseofulvin has produced teratogenic effects in the rat (Klein and Beall, 1972) and cat (Anon. [WHO], 1966) , with multiple malformations observed in cat offspring at therapeutic doses (Scott et al., 1975) . Prolonged oral administration of griseofulvin to mice at elevated doses severely impaired hepatic porphyrin metabolism and caused hepatomegaly (DeMatteis, 1963; DeMatteis et al., 1966; Lochhead et al., 1967) , extensive liver damage (Barich et al., 1961; Hurst and Paget, 1963) and hepatoma induction (DeMatteis et al., 1966; Hurst and Paget, 1963) . Hepatoma induction by griseofulvin was also reported after s.c. administration of milligram quantities to infant mice (Epstein et al., 1967) . A cocarcinogenic effect on skin-tumour development in mice was noted when griseofulvin was administered orally before, during, or after topical treatment with methyleholanthrene (Barich and Barich, 1963; Barich et al., 1960; Barich et al., 1962) .
In this report we present findings from carcinogenicity studies in mice, rats, and hamsters treated for various periods with griseofulvin. 
Treatment
Mice.-Mice were divided into 4 groups and given ad libitum food containing griseofulvin. Groups [1] [2] [3] (Table I) Histologically, liver tumours were either well-differentiated and solid with a structure similar to that of normal liver (Fig. 2) , less differentiated trabecular (Fig. 3) or (occasionally) glandular (Fig. 4) , in which case the liver structure was completely obliterated. The tumour cells in the welldifferentiated neoplasms were arranged in 1-2 cell-thick plates similar to those of the normal liver cords. The intervening sinusoids were narrowed or obliterated because of expanding large neoplastic cells. However, in some areas, particularly in the central portions of large nodules, tumour cells were arrang,ed in small clusters and separated by wide sinusoidal spaces often containing large quantities of blood. The surrounding parenchyma was commonly compressed (Fig. 2) owing to the expansive growth of these tumours. The transition from tumour to the surrounding normal hepatic tissue was sometimes poorly defined. The less-differentiated, trabecular-type tumours consisted of irregular cords several cells thick, and were divided by wide (sometimes narrow) vascular spaces. Occasionally the glandular type of tumour formed acini (Fig. 4) in association with extensive fibrosis.
Cytological irregularities included conspicuous hyalin and refractile eosinophilic inclusion bodies, intranuclear eosinophilic inclusion bodies, vacuolization of cytoplasm (Fig. 3) , frequent basophilia, sometimes extensive pleomorphism and anisokaryosis (Fig. 5) Table I gives treatment and survival rates for test and control rats. In the first 3 weeks of the experiment, the rats tolerated the drug well, but thereafter displayed such signs of toxic effect as somnolence, sometimes slight icterus, and abdominal distention. Toxic effects, although more prominent in male rats, were less intense than in mice, since no animals died within the first 10 weeks of the experiment. Livers showed traces of golden-brown pigment (probably protoporphyrin) in the Kupffer cells, and a virtual absence of such material in liver parenchymal cells.
Thyroid tumours.-The frequency and percentage of tumours are given in Table  III . The incidence of thyroid tumours in Group 1 males (53.30o) and females (2333%) was highly significant (P <-0-001) when compared with the spontaneous incidence in controls (10% for males and 2% for females). Group 2 rats developed fewer thyroid tumours (36.7%o) and females 26 7%, which was still significant for both sexes (P < 0'001). The percentage of thyroid tumours in Group 3 was considerably lower [13.3% in males, statistically significant (P <0 02), and 6-7 % in females]. The ratios of thyroid tumours at the 3 consecutive dose levels indicated a classic dose-response relationship. Grossly, the thyroid tumours varied in size and shape. Large nodules associated with enlargement of the entire lobe were rare. Macroscopically, nodules ranged from 3-10 mm in diameter and appeared well- circumscribed. Histologically, the thyroid tumours were predominantly adenomas, consisting of follicles, which were either of macrofollicular (Fig. 6 ) or macro-and microfollicular types (Fig. 7) and/or of papillary-cystic structures. Since many thyroid adenomas had features of both types of neoplasm, they could be termed mixed thyroid adenomas. The colloid material was usually abundant in macrofollicles and cysts, but appeared scarce or absent in the microfollicles. The follicular epithelium of thyroid tumours was cuboidal and uniform in shape, but more flattened in macrofollicles and cysts. Most thyroid-tumour-bearing animals had cystic cavitations containing various amounts of colloid material within the lesions (in over 70% of all cases). In numerous instances, solitary cysts with colloidal material were found in the thyroid glands of non-tumour-bearing animals. It would appear that the drug exerted some goitrogenic effect on the thyroid. Thyroid carcinomas with varying degrees of anaplasia were of either papillary or follicular types. Some of the carcinomas had distinct papillary projections into the cystic spaces (Fig. 8) and contained sparse amounts of colloidal material. The follicular type of carcinoma was characterized by small follicles lined by cells having dense nuclei with coarse chromatin. The microfollicles were usually devoid of colloidal material. Carcinomas had thick capsules invaded by neoplastic cells (Fig. 9) . No distant metastases of thyroid tumours were found. There were 4 carcinomas (in 3 males and 1 female) in Group 1 and 3 (2 males and 1 female) in Group 3. Three tumours in controls were benign thyroid adenomas. One medullary carcinoma of the thyroid deriving from C cells was encountered in a thyroidadenoma-bearing animal.
Other tumours. -Table III lists other tumours in rats. Group 2 animals had an increased incidence of pituitary gland tumours, predominantly in males, mammary tumours in females, and interstitial-cell tumours of the testes. A squamous-cell tumour of the skin, and tumours of the peripheral nervous system were present in Group 1. Pituitary tumours were mainly adenomas but there were a few carcinomas. Many of these tumours (over 50%)
were associated with thyroid-tumourbearing animals. Over 60% of the females with mammary tumours had pituitary adenomas, but the latter type occurred at an even higher rate (70%) in controls.
The prevailing types of mammary tumours were fibroadenomas, adeno-fibromas and adenomas. Several mammary tumours were adenocarcinomas, which appeared in both control (5) and test (7) groups. The parathyroid tumours in both control and test animals were benign adenomas. The incidence of these tumours in Group 3 does not appear significantly increased when compared with the parathyroid tumours occurring in controls. The skin tumours in Group 1 males were 3 squamous-cell papillomas, one trichoepithelioma and 3 squamous-cell carcinomas, while controls had 6 squamous cell papillomas and 1 squamous-cell carcinoma.
A number of other tumour types in test and control rats (Table III) were representative of lesions commonly found in untreated Eppley rats.
Hamsters
The treatment and survival rates of experimental and control hamsters are given in Table III . Compared to mice and rats, the hamsters tolerated griseofulvin well, and showed no excessive toxic effects.
The incidence of tumours, their distribution and origin showed no significant differeiices between test and control hamsters. The tumour types by group (and latency in weeks) are as follows: Group 1, females-I fibrosarcoma of subcutis (52) 
DISCUSSION
Dietary exposure to griseofulvin produced a significant incidence of hepatocellular tumours in mice, thyroid tumours in rats, but no carcinogenic activity in hamsters.
The total number of hepatomas was particularly significant in mice fed at the 2 highest dose levels, while the rates of hepatocellular tumours decreased proportionately at lower concentrations, indicating a dose response for the incidence of neoplasms in experimental groups. The hepatocarcinogenic effect of griseofulvin and the manifestation of a dose response were reported by Hurst and Paget (1963) who used only 2 dose levels. Subsequently, De Matteis et al. (1966) found a pronounced sex difference in the hepatocellular tumour incidence of mice exposed to griseofulvin, in that males not only showed a greater incidence and multiplicity of these tumours, but also a higher degree of porphyria and more pronounced histological changes in liver. Similarly, hepaticcell tumours have occurred in male mice exposed to milligram quantities of griseofulvin at birth and infancy (Epstein et al. 1967 Little is known of the mechanisms by which griseofulvin is hepatocarcinogenic in mice. Hurst and Paget (1963) suggested that massive deposits of protoporphyrin in finer ramifications of the biliary tract caused biliary cirrhosis, an alteration that could result in neoplasia. However, the strong hepatocarcinogenic effect of the drug in infant mice dosed briefly parenterally (Epstein et al., 1967) indicates an involvement of griseofulvin with cellular constituents (nucleic acids or proteins).
Recently it was suggested that hepatoma induction in mice cannot be held as a valid demonstration of carcinogenicity (Grasso and Crampton, 1972). Tomatis et al. (1973) , however, indicated that induction of liver-cell tumours in mice should be considered as valid a demonstration of carcinogenicity as tumour induction in rats and hamsters.
The finding of thyroid tumours in rats is especially interesting, because in previous studies (Paget and Walpole, 1960; Paget and Alcock, 1960) with this antimitotic drug, no such tumours were reported. These neoplasms have been induced by irradiation (Lindsay et at., 1961; Nichols et al., 1965; Lindsay et al., 1968; Money et al., 1965) , administration of goitrogens (Money et al., 1965) , and by maintaining animals on an iodine-deficient diet. The mechanism of genesis for these tumours is unknown, but in our study over 70% of thyroid-tumour-bearing animals had cystic dilatations containing colloid material, which suggests a possible goitrogenic effect. It is, of course, a matter of speculation whether such an effect may 247 be associated with tumour induction by griseofulvin.
The carcinogenic activity of griseofulvin, as corroborated in this experiment, was formerly limited to mouse liver (DeMatteis et al., 1966; Lochhead et al., 1967) . While previous reports in rats (Klein and Beall, 1972; Paget and Alcock, 1960) have yielded little information about carcinogenicity (perhaps owing to their brevity), our study records positive results in this species. However, further experimental data in rats on the mechanism of induction of thyroid tumours and other neoplasms, including the use of other biological systems for carcinogenicity assay, are required, as are epidemiological studies in man.
